Salesforce, Thermo Fisher Scientific, CrowdStrike And More: CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
CNBC's 'Halftime Report Final Trades' featured stock recommendations from financial experts, including Bryn Talkington, Joshua Brown, Jim Lebenthal, and Jason Snipe. They recommended 3-Month Treasury Bill, CrowdStrike Holdings (CRWD), Thermo Fisher Scientific (TMO), and Salesforce (CRM). CrowdStrike and Salesforce are expected to release their earnings soon.
May 26, 2023 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Salesforce is expected to release earnings next week, with analysts predicting quarterly earnings of $1.61 per share on revenue of $8.18 billion.
Salesforce's upcoming earnings release is expected to have a neutral impact on its stock price in the short term, as the market has likely already priced in the anticipated results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
CrowdStrike is expected to release Q1 earnings on May 31, with analysts predicting earnings of 51 cents per share on revenue of $677.37 million.
CrowdStrike's upcoming earnings release is expected to have a neutral impact on its stock price in the short term, as the market has likely already priced in the anticipated results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Thermo Fisher Scientific is recommended by Jim Lebenthal as a high-quality healthcare company. JPMorgan and Keybanc lowered their price targets on the stock.
Thermo Fisher Scientific's stock price may remain neutral in the short term, as the recommendation by Jim Lebenthal is offset by lowered price targets from JPMorgan and Keybanc.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100